Panel Votes Down New Diet Drug
Tuesday, July 20th, 2010GAITHERSBURG, Md. (MedPage Today) — An FDA advisory panel was divided over whether to recommend the approval of the investigational weight-loss drug phentermine/topiramate (Qnexa), but the Nay votes prevailed 10-6. (Source: MedPage Today Public Health)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and re ceive $5 free advertising.